An overview on Anti-Vegf and in search for an ideal anti VEGF agent
Open Access
- 15 December 2022
- journal article
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical and Experimental Ophthalmology
- Vol. 8 (4), 447-449
- https://doi.org/10.18231/j.ijceo.2022.092
Abstract
An overview on Anti-Vegf and in search for an ideal anti VEGF agent - IJCEO- Print ISSN No: - 2395-1443 Online ISSN No:- 2395-1451 Article DOI No:- 10.18231/j.ijceo.2022.092, Indian Journal of Clinical and Experimental Ophthalmology-Indian J Clin Exp OphthalmolKeywords
This publication has 5 references indexed in Scilit:
- Comparative Efficacy of Brolucizumab in the Treatment of Neovascular Age-Related Macular Degeneration: A Systematic Literature Review and Network Meta-AnalysisAdvances in Therapy, 2022
- KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular EdemaAmerican Journal of Ophthalmology, 2022
- Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS studyPLOS ONE, 2020
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular DegenerationOphthalmology, 2012
- A Brief History of Anti-VEGF for the Treatment of Ocular AngiogenesisThe American Journal of Pathology, 2012